Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Jun 12, 2022
Open Peer Review Period: Jun 12, 2022 - Aug 7, 2022
Date Accepted: Oct 25, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Chatbot-Delivered Cognitive Behavioral Therapy in Adolescents With Depression and Anxiety During the COVID-19 Pandemic: Feasibility and Acceptability Study

Nicol G, Wang R, Graham S, Dodd S, Garbutt J

Chatbot-Delivered Cognitive Behavioral Therapy in Adolescents With Depression and Anxiety During the COVID-19 Pandemic: Feasibility and Acceptability Study

JMIR Form Res 2022;6(11):e40242

DOI: 10.2196/40242

PMID: 36413390

PMCID: 9683529

Chatbot-delivered Cognitive Behavioral Therapy (CBT) in adolescents with depression and anxiety during the COVID-19 pandemic: A pilot acceptability and effectiveness study

  • Ginger Nicol; 
  • Ruoyun Wang; 
  • Sharon Graham; 
  • Sherry Dodd; 
  • Jane Garbutt

ABSTRACT

Background:

Depression, anxiety and related suicidal ideation and self-harm are common among adolescents, and have increased in prevalence and severity during the pandemic to crisis levels, exacerbated by the long-standing workforce shortage of child mental health professionals. As a result, primary care providers are often called on to provide first-line care for these youth. Digital health interventions extend mental health specialty care to youth with moderately severe symptoms, but few are evidence-based. Here, we describe the feasibility of delivering an evidence-based intervention that utilizes a relational conversational agent embedded in a smartphone application (app) to deliver cognitive behavioral therapy (CBT) to adolescents presenting to their PCP for treatment of moderately severe depression and/or anxiety.

Objective:

In this 12-week pilot randomized controlled study, we evaluated the feasibility of the app-based intervention to adolescents ages 13-17 years with moderate depressive symptoms presenting in ambulatory pediatric primary care clinics.

Methods:

We evaluated change in depressive symptom severity as measured by the 9-item Patient Health Questionnaire (PHQ-9), anxiety symptoms via the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7) and self-efficacy for mental health via the Mental Health Self-efficacy Scale (MHSES) at 4 and 12 weeks. Data on acceptability, feasibility and usability were collected from participants, and qualitative interviews were conducted with referring primary care providers (PCPs).

Results:

The pilot randomized 18 participants to treatment plus usual care (n=10) or usual care alone (n=8). There were no difference between groups on baseline characteristics, and all randomized participants completed the program. Although participants in the active treatment group experienced a greater reduction in depressive symptoms than the usual care group, mental health outcomes between groups was not statistically significant. Teen- and parent-reported usability, feasibility and acceptability of the app was high; PCPs reported preference for introducing the app early in the course of care for individuals presenting with mild or moderate symptoms.

Conclusions:

In this small randomized study, we demonstrated the feasibility, acceptability, usability and safety of using a CBT-based chatbot for adolescents presenting with moderate depressive symptoms in real-world primary care settings. Further study is needed to fully determine effectiveness of both the intervention and implementation in primary care settings. Clinical Trial: NCT04603053 (https://clinicaltrials.gov/ct2/show/NCT04603053)


 Citation

Please cite as:

Nicol G, Wang R, Graham S, Dodd S, Garbutt J

Chatbot-Delivered Cognitive Behavioral Therapy in Adolescents With Depression and Anxiety During the COVID-19 Pandemic: Feasibility and Acceptability Study

JMIR Form Res 2022;6(11):e40242

DOI: 10.2196/40242

PMID: 36413390

PMCID: 9683529

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.